Sonoma Pharmaceuticals Inc SNOA
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2007-01-26 |
| Shares Out. | 4,790,000 |
| Website | sonomapharma.com/ ↗ |
| Phone | 18004831140 |
| Employees | 260 |
| Revenue | $5.6M |
| Gross Profit | $2.2M |
| Net Income | -$581,000 |
| Free Cash Flow | -$4.1M |
| Total Assets | $14.0M |
| Total Liabilities | $10.9M |
| Equity | $3.1M |
About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Sonoma Pharmaceuticals Inc is a publicly traded company under the ticker symbol SNOA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)